SMSPHARMA416.00

SMS Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersINDSWFTLABSOLARADCALUNICHEMLABGUFICBIORPGLIFEHIKALGUJTHEMMcap ₹3,896 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment434.2530.8531.2531.2
+ Capital Work-in-Progress30.334.7121.6121.6
+ Other Intangibles2.72.12.82.8
+ Intangibles under Development0.40.00.00.0
+ Non-current Investments10.911.726.326.3
+ Other Non-current Financial Assets7.99.911.211.2
Non-current Financial Assets18.821.637.537.5
+ Other Non-current Assets13.99.031.331.3
Total Non-current Assets500.2598.2724.4724.4
Current Assets
+ Inventories233.7284.7351.2351.2
+ Trade Receivables236.2203.2215.9215.9
+ Cash & Cash Equivalents36.041.445.945.9
+ Other Bank Balances0.20.20.20.2
+ Other Current Financial Assets3.39.93.43.4
Current Financial Assets275.7254.7265.4265.4
+ Other Current Assets22.814.621.421.4
Total Current Assets533.9554.5638.0638.0
Total Assets1,034.11,152.71,362.41,362.4
Equity
+ Equity Share Capital8.58.99.49.4
+ Other Equity / Reserves527.9630.8776.4776.4
Equity — Owners of Parent536.3639.6785.8785.8
+ Minority Interest0.00.00.0
Total Equity536.3639.6785.8785.8
Liabilities
+ Borrowings — Non-current122.1139.4171.6171.6
Non-current Financial Liabilities122.1139.4171.6171.6
+ Provisions — Non-current1.21.21.21.2
+ Deferred Tax Liabilities42.848.150.850.8
Non-current Liabilities166.0188.7223.7223.7
+ Borrowings — Current158.1171.4193.4193.4
+ Trade Payables151.3113.9120.4120.4
+ Other Current Financial Liab16.433.431.831.8
Current Financial Liabilities325.9318.7345.6345.6
+ Provisions — Current1.01.10.90.9
+ Current Tax Liabilities0.00.00.60.6
+ Other Current Liabilities4.84.65.85.8
Current Liabilities331.7324.4353.0353.0
Total Liabilities497.8513.0576.6576.6
Total Equity & Liabilities1,034.11,152.71,362.41,362.4
Assets — additional as-filed lines
+ Current Tax Assets1.70.40.00.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current0.10.20.2
+ Dues to Other Creditors — Current113.8120.2120.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.